A Trial to Assess Consumer Self-Selection and Use of Gabapentin for Occasional Sleeplessness in an Over-the-Counter Environment
NCT ID: NCT00659100
Last Updated: 2021-02-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
1254 participants
INTERVENTIONAL
2006-08-31
2007-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of the Safety of Gabapentin in a Potential Over-the-Counter Population With Occasional Sleeplessness
NCT00666575
Vestipitant 28-day Tolerance Study
NCT00992160
Efficacy and Safety of Ramelteon Combined With Gabapentin in Treating Patients With Insomnia
NCT00755508
Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia
NCT00280423
Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers
NCT01888497
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Gabapentin
Gabapentin 50 mg oral capsule 30 minutes before bedtime
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gabapentin
Gabapentin 50 mg oral capsule 30 minutes before bedtime
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Provided informed consent
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pfizer Investigational Site
Anaheim, California, United States
Pfizer Investigational Site
Bonita, California, United States
Pfizer Investigational Site
Fallbrook, California, United States
Pfizer Investigational Site
Hacienda Heights, California, United States
Pfizer Investigational Site
La Mesa, California, United States
Pfizer Investigational Site
Oceanside, California, United States
Pfizer Investigational Site
Orange, California, United States
Pfizer Investigational Site
San Dimas, California, United States
Pfizer Investigational Site
Pembroke Pines, Florida, United States
Pfizer Investigational Site
Weston, Florida, United States
Pfizer Investigational Site
Baltimore, Maryland, United States
Pfizer Investigational Site
Elk River, Minnesota, United States
Pfizer Investigational Site
Northfield, Minnesota, United States
Pfizer Investigational Site
Red Wing, Minnesota, United States
Pfizer Investigational Site
Saint Louis Park, Minnesota, United States
Pfizer Investigational Site
Holly Springs, Mississippi, United States
Pfizer Investigational Site
Belton, Missouri, United States
Pfizer Investigational Site
Independence, Missouri, United States
Pfizer Investigational Site
Albuquerque, New Mexico, United States
Pfizer Investigational Site
Albuquerque, New Mexico, United States
Pfizer Investigational Site
Taos, New Mexico, United States
Pfizer Investigational Site
Cary, North Carolina, United States
Pfizer Investigational Site
Chapel Hill, North Carolina, United States
Pfizer Investigational Site
Raleigh, North Carolina, United States
Pfizer Investigational Site
Raleigh, North Carolina, United States
Pfizer Investigational Site
Raleigh, North Carolina, United States
Pfizer Investigational Site
Houston, Texas, United States
Pfizer Investigational Site
Pearland, Texas, United States
Pfizer Investigational Site
Bountiful, Utah, United States
Pfizer Investigational Site
Ogden, Utah, United States
Pfizer Investigational Site
Salt Lake City, Utah, United States
Pfizer Investigational Site
Syracuse, Utah, United States
Pfizer Investigational Site
West Valley City, Utah, United States
Pfizer Investigational Site
Falls Church, Virginia, United States
Pfizer Investigational Site
Richmond, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A9451159
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.